Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 66 Rectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Triple Negative Breast Neoplasms 7 Lung Neoplasms 6 Adenocarcinoma of Lung 6 Carcinoma, Intraductal, Noninfiltrating 5 Breast Carcinoma In Situ 4 Pancreatic Neoplasms 2 Unilateral Breast Neoplasms 1 Transsexualism 1 Solitary Pulmonary Nodule 1 Social Isolation 1 Recurrence 1 Piebaldism 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplastic Cells, Circulating 1 Neoplasm Micrometastasis 1 Margins of Excision 1 Lymphedema 1 Local Recurrence of Malignant Tumor of Breast 1 Inflammatory Breast Neoplasms 1 Gynecomastia 1 Gastrointestinal Stromal Tumors 1 Chordoma 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 COVID-19 1

Interventions

telitacicept 2 Prednisone 2 Blood Specimen Collection 2 thymoglobulin 1 remdesivir 1 prednylidene 1 fludarabine 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 apremilast 1 Vitamin D 1 Valsartan 1 Telemedicine 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Pyridostigmine Bromide 1 Practice Guidelines as Topic 1 Population Groups 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Mycophenolic Acid 1 Music Therapy 1 Methods 1 Melphalan 1 Mastectomy, Segmental 1 Mammaplasty 1 Interviews as Topic 1 Infliximab 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Autoimmune Diseases × Mastectomy, Segmental × Clear all

NCT05400954 2023-04-28

AREOLA-B

The Netherlands Cancer Institute

15,000 enrolled

Autoimmune Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡